Sreyashi Basu
0000-0002-5028-3833
The University of Texas MD Anderson Cancer Center
3 papers found
Refreshing results…
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC
Missing publications? Search for publications with a matching author name.